The prevalence of comorbid anxiety in schizophrenia, schizoaffective disorder and bipolar disorder

References

• Wittchen H. Cormorbidity of mood disorders. British Journal of Psychiatry 1996; 168(Suppl. 30)7–134
   Google Scholar
• Argyle N. Panic attacks in chronic schizophrenia. British Journal of Psychiatry 1990; 157: 430–433
   PubMedGoogle Scholar
• Cutler J L, Siris S G. ‘Panic-like’ symptomatology in schizophrenic and schizoaffective patients with postpsychotic depression. Comprehensive Psychiatry 1991; 32: 465–473
   PubMed Web of Science ®Google Scholar
• Penn D L, Hope D A, Spaulding W, Kucera J. Social anxiety in schizophrenia. Schizophrenia Research 1994; 11: 277–284
   PubMed Web of Science ®Google Scholar
• Fenton W S, McGlashen T H. The prognostic significance of obsessive-compulsive symptoms in schizophrenia. American Journal of Psychiatry 1986; 143: 437–441
   PubMed Web of Science ®Google Scholar
• Berman I, Kalinowski A, Berman S M, Lengua J, Green A I. Obsessive and compulsive symptoms in chronic schizophrenia. Comprehensive Psychiatry 1995; 36: 6–10
   PubMed Web of Science ®Google Scholar
• Kruger S, Cooke R G, Hasey G M, Jorna T, Persad E. Cormorbidity of obsessive compulsive disorder in bipolar disorder. Journal of Affective Disorders 1995; 34: 117–120
   PubMed Web of Science ®Google Scholar
• Strakowski S M, Tohen M, Stoll A L, Faedda G L, Goodwin D C. Comorbidity in mania at first hospitalization. American Journal of Psychiatry 1992; 149: 554–556
   PubMed Web of Science ®Google Scholar
• Chen Y, Dilsaver S C. Comorbidity for obsessive-compulsive disorder in bipolar and unipolar disorders. Psychiatry Research 1995; 59: 57–64
   PubMed Web of Science ®Google Scholar
• Chen Y, Dilsaver S C. Comorbidity of panic disorder in bipolar illness: evidence from the Epidemiologic Catchment Area survey. American Journal of Psychiatry 1995; 152: 280–282
   PubMedGoogle Scholar
• Young T, Cooke R G, Robb J, Levitt A J, Joffe R. Anxious and non-anxious bipolar disorder. Journal of Affective Disorders 1993; 29: 49–52
   PubMed Web of Science ®Google Scholar
• Spitzer R L, Williams J B, Gibbon M, First M B. The structured clinical interview for DSM-III-R (SCID). 1: History, rationale and description. Archives of General Psychiatry 1992; 49: 624–629
   PubMed Web of Science ®Google Scholar
• Hallam R S, Hafner R J. Fears of phobic patients: factor analyses of self-report data. Behaviour Research and Therapy 1978; 16: 1–6
   PubMed Web of Science ®Google Scholar
• Marks I M, Mathews A M. Brief standard self-rating for phobic patients. Behaviour Research and Therapy 1979; 17: 263–267
   PubMed Web of Science ®Google Scholar
• Hodgson R J, Rachman S. Obsessional-compulsive complaints. Behaviour Research and Therapy 1977; 15: 389–395
   PubMed Web of Science ®Google Scholar
• Dharwadker N. Effectiveness of an assertive outreach community treatment program. Australian and New Zealand Journal of Psychiatry 1994; 28: 244–249
   PubMed Web of Science ®Google Scholar
• Hambridge J A, Rosen A. Assertive community treatment for the seriously mentally ill in suburban Sydney: a programme description and evaluation. Australian and New Zealand Journal of Psychiatry 1994; 28: 438–455
   PubMed Web of Science ®Google Scholar
• Soni S D, Mallik A, Reed P, Gaskell K. Differences between chronic schizophrenic patients in the hospital and in the community. Hospital and Community Psychiatry 1992; 43: 1233–1238
   PubMedGoogle Scholar
• Myers J K, Weissman M M, Tischler G I, et al. Six-month prevalence of psychiatric disorders in three communities: 1980–1982. Archives of General Psychiatry 1984; 41: 959–967
   PubMed Web of Science ®Google Scholar
• Hafner R J, Crago A, Christensen D, Lia B, Scarborough A. Training case managers in cognitive-behaviour therapy. Australian and New Zealand Journal of Mental Health Nursing 1996; 5: 163–170
   Google Scholar
• Goff D G, Brotman A W, Waites M, McCormick S. Trial of fluoxetine added to neuroleptics for treatment resistant schizophrenic patients. American Journal of Psychiatry 1990; 147: 492–494
   PubMed Web of Science ®Google Scholar
• Goldman M B, Janececk H M. Adjunctive fluoxetine improves global function in chronic schizophrenia. Journal of Neuropsychiatry 1990; 2: 429–431
   PubMedGoogle Scholar
• Zohar J, Kaplan Z, Benjamin J. Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients. Journal of Clinical Psychiatry 1993; 54: 385–388
   PubMed Web of Science ®Google Scholar
• Berman I, Sapers B, Chang H H, et al. Treatment of obsessive-compulsive symptoms in schizophrenic patients with clomipramine. Journal of Clinical Psychopharmacology 1995; 15: 206–210
   PubMedGoogle Scholar